The integration of omics analyses of primary glomerular diseases with data from clinical and histopathological studies is expected to advance our understanding of the molecular basis of these diseases and lead to improvements in diagnosis and treatment. Here, the authors provide an up-to-date overview of omics studies of primary glomerular diseases and suggest new approaches to further characterize their pathogenetic mechanisms, candidate genes, potential biomarkers and therapeutic targets.
- Song Jiang
- Peter Y. Chuang
- John C. He